Meet the Co-chairs - TAGLAW
Blake Morgan LLP
Conner & Winters, LLP
Under the contract terms, Popa & Associates provides legal assistance in gathering information and elaborating technical documentations, developing the business plan, negotiations with public authorities regarding licenses and permits that are necessary to realize the mentioned project, giving a complex legal consultancy throughout the project, implemented with its support and assistance.
Introduction of the public-private partnership (“PPP”) method in the healthcare sector in Turkey has already significantly affected growth of the healthcare sector in the last few years, and new wave of PPP projects over the next five years is expected to be the main driver of expansion in the healthcare services sector. In healthcare PPP projects, the project companies undertake the implementation of the health campus PPP project by executing a private law implementation agreement (i.e., the project agreement) with the Ministry of Health (“MoH”), and the MoH agrees to make certain payments in return. Such payments are used for the repayment of the loans obtained for the project and expenditures of the projects.
By: Jeremy A. Ball, Matthew M. Cobb and Ruth Levy
Donald Trump’s victory in the presidential election combined with Republicans maintaining control of both chambers of Congress has the potential to alter the health care landscape significantly. While little is certain in politics, President-elect Trump and Congressional Republicans have campaigned and pledged for health care reform to include the repeal and replacement of the Affordable Care Act (ACA).
Contact: David Black
Last night the Florida Right to Medical Marijuana Initiative, Amendment 2, received 71 percent approval, far more than the 60 percent required for passage. The passage of Amendment 2 will expand the marijuana industry in Florida – currently dominated by the 2014 Compassionate Medical Cannabis Act, commonly known as Florida’s “Charlotte’s Web” law – opening the floodgates to what is expected to be a lucrative $1.5 billion industry by 2020.
In a much anticipated decision, the Federal Court last week found in favour of a manufacturer of generic veterinary products in its action against the Australian Pesticides and Veterinary Medicines Authority (APVMA). Partner, Dr Teresa Nicoletti and Lawyer, Sebastian Tonkin discuss this decision further.